# Spencer Nadolsky

قسمت های برتر پادکست
به روز شده:

GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton

· رونوشت
Dr. Spencer Nadolsky and Karl sit down with Dr. Adam Auton, geneticist at 23andMe, to break down a brand new paper using data from over 27,000 people that identified specific genetic variants linked to how well GLP-1 medications work and how likely someone is to experience side effects. 23andMe has…

Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer

· رونوشت
5:37 PM         Dr. Spencer Nadolsky and Karl sit down with Dr. Henning Langer, PhD researcher at the Charité in Berlin and founder of his own muscle metabolism lab, to break down his newly published paper combining rodent and human data to look directly at what GLP-1 medicines actually do to skele…

How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips

· رونوشت
Dr. Spencer Nadolsky and Dr. Karl Nadolsky sit down with Dr. Stuart Phillips, senior author on the newly updated American College of Sports Medicine position stand on resistance training, to break down what 137 systematic reviews and over 30,000 participants actually tell us about building muscle, …

Bimagrumab and Semaglutide: The BELIEVE Trial Results With Dr. Steven Heymsfield

· رونوشت
Dr. Spencer Nadolsky, Dr. Karl, and chief science officer Dr. Grant Tinsley sit down with Dr. Steven Heymsfield, physician at the Pennington Biomedical Research Center and lead author on the BELIEVE trial, to break down what happens when you combine bimagrumab with semaglutide and why over 90 perce…

CVS Pulled the Plug on Zepbound?!

In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the recent changes in obesity medication coverage, particularly focusing on the CVS Caremark decision to drop ZEPBound from their formulary in favor of Wegovi. They explore the implications of this decision for…

More Than Weight Loss? GLP-1s and Cardiovascular Risk

In this episode of the Dr. Lift podcast, hosts Dr. Spencer Nadolsky and Dr. Karl discuss the Surpass CVOT trial, which evaluates the cardiovascular outcomes of Monjaro compared to Dulaglutide (Trulicity). They delve into the significance of the trial, the implications of the results, and the potent…

Nonalcoholic Fatty Liver Disease (NAFLD)

Drs. Karl and Spencer Nadolsky discuss screening for and treating nonalcoholic fatty liver disease (NAFLD). Learn: - What NAFLD is - Why you should be aware of it - The difference between nonalcoholic fatty liver and nonalcoholic steatohepatitis - What to do if you get it - What diets are best to t…

Intermittent Fasting and Weight Loss

Drs. Karl and Spencer Nadolsky discuss the new study on intermittent fasting from the New England Journal of Medicine. You'll learn: - What types of intermittent fasting methods are out there - If they help you lose weight more than just cutting calories in general - If there are other benefits bey…

How to Diagnose Obesity

· رونوشت
The medical diagnosis of obesity isn't as simple as a BMI anymore. Take a listen to Drs. Karl and Spencer Nadolsky discuss how it should be diagnosed when you walk into a doctor's office. AACE Obesity Guidelines Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our…

You don't have adrenal fatigue

· رونوشت
Drs. Karl and Spencer Nadolsky discuss why you're tired and how it is not adrenal fatigue. Learn: - Adrenal gland physiology and pathology - What "adrenal fatigue" allegedly is - Other causes of fatigue - What to do about it Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for informat…